Florida 2026 Session Status: To Executive 1 R cosponsors

SB 1092 — Podiatric Medicine

Last action — Chapter No. 2026-124

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Senate
  4. ✓
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been sent to the executive. Introduced January 05, 2026. It awaits signature.

Signed by Governor Ron DeSantis (Republican) on June 09, 2026.

Next likely step: the executive signs it into law or issues a veto.

Odds of enactment

Moderate chance

Based on the sponsor, cosponsors, and committee posture, this bill has a moderate chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Likely to advance 64% · moderate confidence

  • To Executive

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (1 R).

  • Cleared a recorded vote

    Passed 8 recorded votes so far.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

In plain language

The bill updates requirements for podiatric physicians regarding continuing education and the use of certain products.

This bill requires specific podiatric physicians to complete continuing education. It allows them to use unapproved cellular or tissue-based products after obtaining patient consent.

What this means for you
  • Workers: Podiatric physicians may need to adapt their continuing education and consent processes under this bill.

Summary

Podiatric Medicine; Requiring certain podiatric physicians, instead of all podiatric physicians, to complete specified continuing education; authorizing podiatric physicians to perform procedures using cellular or tissue-based products not approved by the United States Food and Drug Administration under certain circumstances; specifying requirements for the cellular or tissue-based products that may be used by such podiatric physicians; requiring podiatric physicians to obtain a signed consent form from the patient or his or her representative before performing procedures using cellular or tissue-based products, etc.

Bill Text

What changed in the latest version

228 added · 196 removed

228 line(s) added, 196 removed.

→
Previous
Latest
Florida Senate - 2026 CS for CS for SB 1092 By the Appropriations Committee on Health and Human Services;
Florida Senate - 2026 CS for SB 1092 By the Committee on Health Policy;
the Committee on Health Policy;
and Senator Massullo 588-02785-26 20261092c1 A bill to be entitled An act relating to podiatric medicine;
and Senator Massullo 603-02960-26 20261092c2 A bill to be entitled An act relating to podiatric medicine;
authorizing podiatric physicians to perform procedures using cellular or tissue-based products not approved by the United States Food and Drug Administration under certain circumstances;
authorizing podiatric physicians to perform stem cell therapy not approved by the United States Food and Drug Administration under certain circumstances;
specifying requirements for the cellular or tissue- based products that may be used by such podiatric physicians;
specifying requirements for the stem cells that may be used by such podiatric physicians;
requiring such podiatric physicians to include a specified notice in any form of advertisement;
requiring podiatric physicians who perform such therapies to use stem cell therapy products obtained from facilities that adhere to applicable current good manufacturing practices;
requiring podiatric physicians to include a specified notice in any form of advertisement;
requiring podiatric physicians to obtain a signed consent form from the patient or his or her representative before performing procedures using cellular or tissue-based products;
requiring podiatric physicians to obtain a signed consent form from the patient or his or her representative before performing such stem cell therapy;
Subsection (3) of section 461.007, Florida Statutes, is amended to read:
Subsection (3) of section 461.007, Florida Page 1 of 8 CODING:
Page 1 of 7 CODING:
Florida Senate - 2026 CS for CS for SB 1092 603-02960-26 20261092c2 461.007 Renewal of license.— (3) The board may by rule prescribe continuing education, not to exceed 40 hours biennially, as a condition for renewal of a license, with a minimum of 2 hours of continuing education related to the safe and effective prescribing of controlled substances for licensees who are registered with the United States Drug Enforcement Administration and authorized to prescribe controlled substance pursuant to 21 U.S.C.
Florida Senate - 2026 CS for SB 1092 588-02785-26 20261092c1 Statutes, is amended to read:
461.007 Renewal of license.— (3) The board may by rule prescribe continuing education, not to exceed 40 hours biennially, as a condition for renewal of a license, with a minimum of 2 hours of continuing education related to the safe and effective prescribing of controlled substances for licensees who are registered with the United States Drug Enforcement Administration and authorized to prescribe controlled substance pursuant to 21 U.S.C.
461.011 Cellular and tissue-based products.— (1) The Legislature recognizes the significant potential of cellular and tissue-based products in advancing medical treatments and improving patient outcomes and further recognizes the need to ensure that such treatments are provided using cellular or tissue-based products obtained in an ethical manner that does not involve cells derived from aborted fetuses.
461.011 Stem cell therapy.— (1) The Legislature recognizes the significant potential of stem cell therapies in advancing medical treatments and improving patient outcomes and further recognizes the need to ensure that such therapies are provided using stem cells obtained in an ethical manner that does not involve stem cells derived from aborted fetuses.
By encouraging the use of cellular or tissue-based products, the state will advance regenerative medicine in a manner consistent with the values of the state.
By encouraging the use of stem cell sources such as adult stem cells, umbilical cord blood, and other ethically obtained human cells, tissues, or cellular or tissue-based products, the state will advance regenerative medicine in a manner consistent with the values of this state.
(a) “Cellular or tissue-based products” means products containing or consisting of human cells or tissues which are intended for implantation, transplantation, infusion, or transfer into a human recipient.
(a) “Human cells, tissues, or cellular or tissue-based Page 2 of 8 CODING:
The term does not include:
Page 2 of 7 CODING:
Florida Senate - 2026 CS for CS for SB 1092 603-02960-26 20261092c2 1.
Florida Senate - 2026 CS for SB 1092 588-02785-26 20261092c1 products” means articles containing or consisting of human cells or tissues that are intended for implantation, transplantation, infusion, or transfer into a human recipient.
The term does not include:
1.
8.
or 8.
Blood vessels recovered with an organ which are intended for use in organ transplantation and labeled “For use in organ transplantation only”;
Blood vessels recovered with an organ which are intended for use in organ transplantation and labeled “For use in organ transplantation only.” (b) “Minimally manipulated” means:
or 9.
Harvesting and reimplantation of autologous tissue.
(b) “Minimally manipulated” means:
(c) “Procedure using cellular or tissue-based products” means a treatment involving the use of human cells, tissues, or cellular or tissue-based products which complies with the regulatory requirements provided in this section.
(c) “Stem cell therapy” means a treatment involving the use Page 3 of 8 CODING:
The term does Page 3 of 7 CODING:
Florida Senate - 2026 CS for CS for SB 1092 603-02960-26 20261092c2 not include treatment or research using human cells or tissues derived from a fetus or an embryo after an abortion.
Florida Senate - 2026 CS for SB 1092 588-02785-26 20261092c1 of human cells, tissues, or cellular or tissue-based products which complies with the regulatory requirements provided in this section.
(3)(a) A podiatric physician may perform a procedure using cellular or tissue-based products that are not approved by the United States Food and Drug Administration if such products are used for treatment or procedures within the scope of practice for such podiatric physician and the treatment or procedures are related to connective tissue, ligament, and tendon repair;
The term does not include treatment or research using human cells or tissues that were derived from a fetus or an embryo after an abortion.
wound care;
(3)(a) A podiatric physician may perform stem cell therapy that is not approved by the United States Food and Drug Administration if such therapy is used for treatment or procedures that are within the scope of practice for such podiatric physician and the therapies are related to orthopedics, wound care, or pain management.
or pain management.
(b) To ensure that the retrieval, manufacture, storage, and use of stem cells used for therapies conducted under this section meet the highest standards, any stem cells used by a podiatric physician for therapy provided under this section must meet all of the following conditions:
(b) To ensure that the retrieval, manufacture, storage, and use of any cellular or tissue-based products pursuant to this section meet the highest standards, any cellular or tissue-based products used by a podiatric physician for a procedure provided under this section must meet all of the following conditions:
Contain viable or live cells upon post-thaw analysis and be included in a post-thaw viability analysis report for the product lot, which must be sent to the podiatric physician before use with the podiatric physician’s patient.
Contain viable or live cells upon post-thaw analysis and be included in a post-thaw viability analysis report for the Page 4 of 8 CODING:
Page 4 of 7 CODING:
Florida Senate - 2026 CS for CS for SB 1092 603-02960-26 20261092c2 (4)(a) A podiatric physician who performs a procedure using cellular or tissue-based products pursuant to this section shall include the following in any form of advertisement:
Florida Senate - 2026 CS for SB 1092 588-02785-26 20261092c1 product lot which will be sent to the podiatric physician before use with the podiatric physician’s patient.
(c) A podiatric physician performing stem cell therapy may obtain stem cells for therapies from a facility engaging in the retrieval, manufacture, or storage of stem cells intended for human use under this section only if the facility maintains valid certification or accreditation as required by this subsection.
Any contract or other agreement by which a podiatric physician obtains stem cells for therapies from such a facility must include the following:
1.
A requirement that the facility provide all of the following information to the podiatric physician:
a.
Show all 84 changed rows (44 more)
Previous
Latest
The name and address of the facility.
b.
The certifying or accrediting organization.
c.
The type and scope of certification or accreditation.
d.
The effective and expiration dates of the certification or accreditation.
e.
Any limitations or conditions imposed by the certifying or accrediting organization.
2.
A requirement that the facility notify the podiatric physician within 30 days after any change in certification or accreditation status, including renewal, suspension, revocation, or expiration.
(4) In the performance of any procedure using or purporting to use stem cells or products containing stem cells, the podiatric physician shall use stem cell therapy products obtained from facilities that adhere to the applicable current good manufacturing practices for the collection, removal, processing, implantation, and transfer of stem cells, or Page 5 of 8 CODING:
Words stricken are deletions;
words underlined are additions.
Florida Senate - 2026 CS for SB 1092 588-02785-26 20261092c1 products containing stem cells, pursuant to the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.
ss.
301 et seq.;
52 Stat.
1040 et seq.;
and 21 C.F.R.
part 1271, Human Cells, Tissues, and Cellular and Tissue-Based Products.
(5)(a) A podiatric physician who conducts stem cell therapy pursuant to this section shall include the following in any form of advertisement:
This podiatric physician performs procedures using cellular or tissue-based products that have not yet been approved by the United States Food and Drug Administration.
This podiatric physician performs one or more stem cell therapies that have not yet been approved by the United States Food and Drug Administration.
You are encouraged to consult with your primary care provider before undergoing any procedure using these products.
You are encouraged to consult with your primary care provider before undergoing any stem cell therapy.
(5)(a) A podiatric physician who performs a procedure using cellular or tissue-based products pursuant to this section shall obtain a signed consent form from the patient before performing the procedure.
(6)(a) A podiatric physician who conducts stem cell therapy pursuant to this section shall obtain a signed consent form from the patient before performing the stem cell therapy.
(b) The consent form must be signed by the patient or, if the patient is not legally competent, the patient’s representative, and must state all of the following in language the patient or his or her representative may reasonably be expected to understand:
(b) The consent form must be signed by the patient or, if the patient is not legally competent, the patient’s representative and must state all of the following in language the patient or his or her representative may reasonably be expected to understand:
That the proposed procedure uses cellular or tissue- based products that have not yet been approved by the United States Food and Drug Administration.
That the proposed stem cell therapy has not yet been approved by the United States Food and Drug Administration.
3.
Page 6 of 8 CODING:
The anticipated results of the proposed treatment.
Page 5 of 7 CODING:
Florida Senate - 2026 CS for CS for SB 1092 603-02960-26 20261092c2 4.
Florida Senate - 2026 CS for SB 1092 588-02785-26 20261092c1 3.
The anticipated results of the proposed treatment.
4.
That the patient is encouraged to consult with his or her primary care provider before undergoing the procedure.
That the patient is encouraged to consult with his or her primary care provider before undergoing any stem cell therapy.
(6) This section does not apply to the following:
(7) This section does not apply to the following:
or (b) A podiatric physician who performs procedures using cellular or tissue-based products under an employment or other contract on behalf of an institution certified or accredited by any of the following:
or (b) A podiatric physician who performs stem cell therapy under an employment or other contract on behalf of an institution certified or accredited by any of the following:
(7) A violation of this section may subject the podiatric physician to disciplinary action by the board.
(8) A violation of this section may subject the podiatric physician to disciplinary action by the board.
(8) A podiatric physician who willfully performs, or actively participates in, the following commits a felony of the third degree, punishable as provided in s.
(9) A podiatric physician who willfully performs, or actively participates in, the following commits a felony of the third degree, punishable as provided in s.
(a) Treatment or research using human cells or tissues derived from a fetus or an embryo after an abortion;
(a) Treatment or research using human cells or tissues Page 7 of 8 CODING:
or Page 6 of 7 CODING:
Florida Senate - 2026 CS for CS for SB 1092 603-02960-26 20261092c2 (b) The sale, manufacture, or distribution of computer products created using human cells, tissues, or cellular or tissue-based products.
Florida Senate - 2026 CS for SB 1092 588-02785-26 20261092c1 derived from a fetus or an embryo after an abortion;
(9) The board may adopt rules necessary to implement this section.
or (b) The sale, manufacture, or distribution of computer products created using human cells, tissues, or cellular or tissue-based products.
(10) The board may adopt rules necessary to implement this section.
Page 7 of 7 CODING:
Page 8 of 8 CODING:
⬇ Download PDF
View plain text versions (4)

How this bill changes current law

10 changes Share ↗

AI-generated reading aid from the bill's amendatory text — verify against the official bill.

The bill restricts certain continuing education requirements for podiatric physicians and establishes regulations for the use of cellular or tissue-based products in podiatry.

  • Section 461.007

    all podiatric physicians → certain podiatric physicians

    Only certain podiatric physicians are now required to complete specified continuing education.

  • Section 461.011

    Section 461.011 Cellular and tissue-based products.—(1) The Legislature recognizes the significant potential of cellular and tissue-based products in advancing medical treatments...

    Creates a new section that defines and regulates the use of cellular and tissue-based products by podiatric physicians.

  • Section 461.011

    A podiatric physician may perform a procedure using cellular or tissue-based products that are not approved by the United States Food and Drug Administration...

    Authorizes certain podiatric physicians to use unapproved cellular or tissue-based products under specific conditions.

  • Section 461.011

    To ensure that the retrieval, manufacture, storage, and use of any cellular or tissue-based products pursuant to this section meet the highest standards...

    Establishes conditions that cellular or tissue-based products must meet before being used in procedures.

  • Section 461.011

    A podiatric physician who performs a procedure using cellular or tissue-based products pursuant to this section shall include the following in any form of advertisement...

    Mandates specific disclosure in advertisements regarding the use of cellular or tissue-based products.

  • Section 461.011

    A podiatric physician who performs a procedure using cellular or tissue-based products pursuant to this section shall obtain a signed consent form from the patient...

    Requires podiatric physicians to obtain informed consent from patients before performing procedures using certain products.

  • Section 461.011

    This section does not apply to the following: (a) A podiatric physician who has obtained approval for an investigational new drug or device...

    Exempts certain podiatric physicians from the regulations if they have FDA approval for their procedures.

  • Section 461.011

    A violation of this section may subject the podiatric physician to disciplinary action by the board.

    Establishes disciplinary measures for podiatric physicians who violate the new regulations.

  • Section 461.011

    A podiatric physician who willfully performs, or actively participates in, the following commits a felony of the third degree...

    Imposes criminal penalties on podiatric physicians for serious violations related to fetal tissues.

  • Section 461.011

    The board may adopt rules necessary to implement this section.

    Gives the Board of Podiatric Medicine the authority to create rules for implementing these changes.

Action History

  1. Chapter No. 2026-124

  2. Approved by Governor

  3. Signed by Officers and presented to Governor

  4. Ordered enrolled

  5. CS passed; YEAS 112, NAYS 0

  6. Read 3rd time

  7. Added to Third Reading Calendar

  8. Read 2nd time

  9. 1st Reading (Committee Substitute 2)

  10. Bill added to Special Order Calendar (3/10/2026)

  11. Bill referred to House Calendar

  12. In Messages

  13. Immediately certified -SJ 463

  14. CS passed; YEAS 35 NAYS 0 -SJ 447

  15. Read 3rd time -SJ 447

  16. Read 2nd time -SJ 447

  17. Placed on Special Order Calendar, 02/26/26

  18. Placed on Calendar, on 2nd reading

  19. Favorable by- Rules; YEAS 23 NAYS 0

  20. CS/CS by Appropriations Committee on Health and Human Services read 1st time

  21. On Committee agenda-- Rules, 02/24/26, 12:00 pm, 412 Knott Building

  22. Now in Rules

  23. Pending reference review under Rule 4.7(2) - (Committee Substitute)

  24. CS by Health Policy read 1st time

  25. CS/CS by Appropriations Committee on Health and Human Services; YEAS 9 NAYS 0

  26. On Committee agenda-- Appropriations Committee on Health and Human Services, 02/18/26, 8:30 am, 412 Knott Building

  27. Now in Appropriations Committee on Health and Human Services

  28. Pending reference review under Rule 4.7(2) - (Committee Substitute)

  29. CS by Health Policy; YEAS 11 NAYS 0

  30. On Committee agenda-- Health Policy, 02/11/26, 3:00 pm, 412 Knott Building

  31. Introduced

  32. Referred to Health Policy; Appropriations Committee on Health and Human Services; Rules

  33. Filed

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 163 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (163)

163 members have not signed on to this bill.

Show all 163 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Third Reading

Passed 35 Yea · 0 Nay · 4 Other
Party YeaNayPresentNot Voting
Democrat 9001
Republican 24003
Unaffiliated 1000
No Party Affiliation 1000
Total 35004
% of votes cast 90%0%0%10%
How each member voted (39)
Member Party Vote
Smith — Yea
Arrington, Kristen Aston Democrat Yea
Berman, Lori Democrat Yea
Bernard, Mack Democrat Yea
Davis, Tracie Democrat Yea
Davis, Tracie Democrat Yea
Jones, Shevrin D. "Shev" Democrat Yea
Osgood, Rosalind Democrat Yea
Polsky, Tina Scott Democrat Yea
Rouson, Darryl Ervin Democrat Yea
Sharief, Barbara Democrat Not Voting
Pizzo, Jason W. B. No Party Affiliation Yea
Albritton, Ben Republican Yea
Boyd, Jim Republican Yea
Bradley, Jennifer Republican Not Voting
Brodeur, Jason Republican Yea
Burgess, Danny Republican Yea
Burton, Colleen Republican Yea
Calatayud, Alexis Republican Yea
DiCeglie, Nick Republican Yea
Gaetz, Don Republican Yea
Garcia, Ileana Republican Not Voting
Grall, Erin Republican Yea
Gruters, Joe Republican Not Voting
Harrell, Gayle Republican Yea
Hooper, Ed Republican Yea
Leek, Thomas J. "Tom" Republican Yea
Martin, Jonathan Republican Yea
Massullo, Ralph E., Jr. Republican Yea
Mayfield, Debbie Republican Yea
McClain, Stan Republican Yea
Passidomo, Kathleen Republican Yea
Rodriguez, Ana Maria Republican Yea
Simon, Corey Republican Yea
Truenow, Keith L. Republican Yea
Trumbull, Jay Republican Yea
Vacant Republican Yea
Wright, Tom A. Republican Yea
Yarborough, Clay Republican Yea

Official roll call →

Passage, Third Reading

Passed 112 Yea · 0 Nay · 5 Other
Party YeaNayPresentNot Voting
Republican 80003
Democrat 31002
Unaffiliated 1000
Total 112005
% of votes cast 96%0%0%4%
How each member voted (117)
Member Party Vote
Tomkow — Yea
Alvarez, Jose Democrat Yea
Antone, Bruce Hadley Democrat Yea
Aristide, Wallace Democrat Yea
Bartleman, Robin Democrat Yea
Campbell, Daryl Democrat Yea
Chambliss, Kevin D. Democrat Yea
Cross, Lindsay Democrat Yea
Daley, Dan Democrat Yea
Daniels, Kimberly Democrat Yea
Driskell, Fentrice Democrat Yea
Dunkley, Lisa Democrat Yea
Edmonds, Jervonte "Tae" Democrat Yea
Eskamani, Dr. Anna V. Democrat Yea
Franklin II, Gallop Democrat Yea
Gantt, Ashley Viola Democrat Yea
Gottlieb, Michael "Mike" Democrat Yea
Harris, Jennifer "Rita" Democrat Yea
Hart-Lowman, Dianne "Ms Dee" Democrat Yea
Hinson, Yvonne Hayes Democrat Yea
Hunschofsky, Christine Democrat Yea
Joseph, Dotie Democrat Not Voting
Long, Rob Democrat Yea
López, Johanna Democrat Yea
Nixon, Angela "Angie" Democrat Yea
Rayner, Michele K. Democrat Yea
Robinson, Felicia Simone Democrat Not Voting
Rosenwald, Mitch Democrat Yea
Skidmore, Kelly Democrat Yea
Spencer, Leonard Democrat Yea
Tant, Allison Democrat Yea
Tendrich, Debra Democrat Yea
Woodson, Marie Paule Democrat Yea
Young, RaShon Democrat Yea
Abbott, Shane G. Republican Yea
Albert, Jon Republican Yea
Alvarez, Daniel Antonio "Danny" Republican Yea
Anderson, Adam Republican Yea
Andrade, Robert Alexander "Alex" Republican Yea
Baker, Jessica Republican Yea
Bankson, Douglas Michael "Doug" Republican Yea
Barnaby, Webster Republican Yea
Basabe, Fabián Republican Yea
Benarroch, Yvette Republican Yea
Berfield, Kimberly Republican Yea
Black, Dean Republican Yea
Blanco, Omar Republican Yea
Booth, Erika Republican Yea
Borrero, David Republican Yea
Botana, Adam Republican Yea
Boyles, Nathan Republican Yea
Brackett, Robert A. "Robbie" Republican Yea
Brannan III, Robert Charles "Chuck" Republican Yea
Buchanan, James Republican Yea
Busatta, Demi Republican Yea
Canady, Jennifer Republican Yea
Cassel, Hillary Republican Yea
Chamberlin, Ryan Republican Yea
Chaney, Linda Republican Yea
Cobb, Nan Republican Yea
Conerly, William "Bill" Republican Yea
Duggan, Wyman Republican Yea
Esposito, Tiffany Republican Yea
Fabricio, Tom Republican Yea
Garrison, Sam Republican Yea
Gentry, Richard Republican Yea
Gerwig, Anne Republican Yea
Giallombardo, Mike Republican Yea
Gonzalez Pittman, Karen Republican Yea
Gossett-Seidman, Peggy Republican Yea
Greco, Sam Republican Yea
Griffitts Jr., Philip Wayne "Griff" Republican Not Voting
Grow, J.J. Republican Yea
Hodgers, Brian Republican Yea
Holcomb, Jeff Republican Yea
Jacques, Berny Republican Yea
Johnson, Chad Republican Yea
Kendall, Kim Republican Yea
Kincart Jonsson, Jennifer Republican Yea
Koster, Traci Republican Yea
LaMarca, Chip Republican Yea
Maggard, Randall Scott "Randy" Republican Yea
Maney, Patt Republican Yea
McClure, Lawrence Republican Yea
McFarland, Fiona Republican Yea
Melo, Lauren Republican Yea
Michael, Kiyan Republican Yea
Miller, Monique Republican Yea
Mooney Jr., James Vernon "Jim" Republican Yea
Nix Jr., Danny Republican Yea
Oliver, Vanessa Republican Yea
Overdorf, Tobin Rogers "Toby" Republican Yea
Owen, Michael Republican Yea
Partington, Bill Republican Not Voting
Perez, Daniel Republican Yea
Persons-Mulicka, Jenna Republican Yea
Plakon, Rachel Saunders Republican Yea
Plasencia, Susan Republican Not Voting
Porras, Juan Carlos Republican Yea
Redondo, Mike Republican Yea
Rizo, Alex Republican Yea
Robinson Jr., William Cloud "Will" Republican Yea
Salzman, Michelle Republican Yea
Sapp, Judson Republican Yea
Shoaf, Jason Republican Yea
Sirois, Tyler I. Republican Yea
Smith, David Republican Yea
Snyder, John Republican Yea
Stark, Paula A. Republican Yea
Steele, Kevin M. Republican Yea
Trabulsy, Dana Republican Yea
Tramont, Chase Republican Yea
Tuck, Kaylee Republican Yea
Valdés, Susan L. Republican Yea
Weinberger, Meg Republican Yea
Yarkosky, Taylor Michael Republican Yea
Yeager, Bradford Troy "Brad" Republican Yea

Official roll call →

Third Reading

Passed 35 Yea · 0 Nay · 4 Other
Party YeaNayPresentNot Voting
Democrat 9001
Republican 25003
No Party Affiliation 1000
Total 35004
% of votes cast 90%0%0%10%
How each member voted (39)
Member Party Vote
Arrington, Kristen Aston Democrat Yea
Berman, Lori Democrat Yea
Bernard, Mack Democrat Yea
Bracy Davis, LaVon Democrat Yea
Davis, Tracie Democrat Yea
Jones, Shevrin D. "Shev" Democrat Yea
Osgood, Rosalind Democrat Yea
Polsky, Tina Scott Democrat Yea
Rouson, Darryl Ervin Democrat Yea
Sharief, Barbara Democrat Not Voting
Pizzo, Jason W. B. No Party Affiliation Yea
Albritton, Ben Republican Yea
Boyd, Jim Republican Yea
Bradley, Jennifer Republican Not Voting
Brodeur, Jason Republican Yea
Burgess, Danny Republican Yea
Burton, Colleen Republican Yea
Calatayud, Alexis Republican Yea
DiCeglie, Nick Republican Yea
Gaetz, Don Republican Yea
Garcia, Ileana Republican Not Voting
Grall, Erin Republican Yea
Gruters, Joe Republican Not Voting
Harrell, Gayle Republican Yea
Hooper, Ed Republican Yea
Leek, Thomas J. "Tom" Republican Yea
Martin, Jonathan Republican Yea
Massullo, Ralph E., Jr. Republican Yea
Mayfield, Debbie Republican Yea
McClain, Stan Republican Yea
Passidomo, Kathleen Republican Yea
Rodriguez, Ana Maria Republican Yea
Simon, Corey Republican Yea
Smith, David Republican Yea
Truenow, Keith L. Republican Yea
Trumbull, Jay Republican Yea
Vacant Republican Yea
Wright, Tom A. Republican Yea
Yarborough, Clay Republican Yea

Official roll call →

Favorable

Passed 23 Yea · 0 Nay · 1 Other
Party YeaNayPresentNot Voting
Republican 18000
Democrat 5000
No Party Affiliation 0001
Total 23001
% of votes cast 96%0%0%4%
How each member voted (24)
Member Party Vote
Berman, Lori Democrat Yea
Davis, Tracie Democrat Yea
Jones, Shevrin D. "Shev" Democrat Yea
Osgood, Rosalind Democrat Yea
Rouson, Darryl Ervin Democrat Yea
Pizzo, Jason W. B. No Party Affiliation Not Voting
Boyd, Jim Republican Yea
Bradley, Jennifer Republican Yea
Brodeur, Jason Republican Yea
Burgess, Danny Republican Yea
Burton, Colleen Republican Yea
DiCeglie, Nick Republican Yea
Gaetz, Don Republican Yea
Garcia, Ileana Republican Yea
Grall, Erin Republican Yea
Harrell, Gayle Republican Yea
Hooper, Ed Republican Yea
Martin, Jonathan Republican Yea
Passidomo, Kathleen Republican Yea
Rodriguez, Ana Maria Republican Yea
Simon, Corey Republican Yea
Trumbull, Jay Republican Yea
Vacant Republican Yea
Wright, Tom A. Republican Yea

Official roll call →

Favorable with Committee Substitute

Passed 9 Yea · 0 Nay
Party YeaNayPresentNot Voting
Republican 6000
Democrat 3000
Total 9000
% of votes cast 100%0%0%0%
How each member voted (9)
Member Party Vote
Davis, Tracie Democrat Yea
Rouson, Darryl Ervin Democrat Yea
Sharief, Barbara Democrat Yea
Brodeur, Jason Republican Yea
Burton, Colleen Republican Yea
Garcia, Ileana Republican Yea
Harrell, Gayle Republican Yea
Rodriguez, Ana Maria Republican Yea
Trumbull, Jay Republican Yea

Official roll call →

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 1092 do?
Podiatric Medicine; Requiring certain podiatric physicians, instead of all podiatric physicians, to complete specified continuing education; authorizing podiatric physicians to perform procedures using cellular or tissue-based products not approved by the United States Food and Drug Administration under certain circumstances; specifying requirements for the cellular or tissue-based products that may be used by such podiatric physicians; requiring podiatric physicians to obtain a signed consent form from the patient or his or her representative before performing procedures using cellular or tissue-based products, etc.
Who sponsors SB 1092?
SB 1092 is sponsored by Massullo, Ralph E., Jr. (Republican).
What is the current status of SB 1092?
This bill has been sent to the executive. Introduced January 05, 2026. It awaits signature.
Where can I track SB 1092?
Track SB 1092 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 1092

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 1092

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →